This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rudong Ruien Pharmaceutical Technology Co. Ltd. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **Innovative Contributions of Yu Qian in Antibacterial and Antitumor Research**
Introduction
Yu Qian, an accomplished inventor based in Shanghai, China, has made significant strides in the fields of antibacterial and anticancer research. With a keen interest in novel therapeutic agents, he has developed an innovative method through his unique patent that targets resistant bacterial strains and cancer cells effectively.
Latest Patents
Yu Qian holds a noteworthy patent for "Spiro Three-Membered Ring and Spiro Five-Membered Ring Peptide Deformylase Inhibitor and Use Thereof in Antibacteria and Anti-Tumor." This invention showcases the anti-bacterial activity and anti-tumor potential of new spiro compounds that inhibit peptide deformylase. These inhibitors selectively attack antibiotic-resistant Gram-positive bacteria by disrupting bacterial protein synthesis while sparing human protein processes. Additionally, these compounds impair the energy balance in cancer cells, promoting apoptosis in various cancer strains, including colorectal cancer, leukemia, lung cancer, and more, even at relatively lower concentrations.
Career Highlights
Currently, Yu Qian is associated with Rudong Ruien Pharmaceutical Technology Co., Ltd., where he continues to explore new avenues for drug development. His contributions to the field of medicinal chemistry and his innovative patent mark him as a key figure in the scientific community focused on combating resistant infections and cancer.
Collaborations
Throughout his career, Yu Qian has collaborated with colleagues such as Wenhao Hu and Fengping Lv. Their teamwork emphasizes a unified approach in tackling complex health issues through research and development of effective therapeutic agents.
Conclusion
Yu Qian's innovative work in developing spiro peptide deformylase inhibitors highlights the potential of new therapies in the fight against bacterial resistance and various cancers. As he continues to collaborate and contribute to pharmaceutical advancements, his research promises to pave the way for more effective medical treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile